^
+ Follow RISEDRONATE Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 373782
                    [Title] => Study compares two osteoporosis drugs
                    [Summary] => 

A retrospective study of over 33,000 postmenopausal women showed that among patients prescribed one of the two most popular osteoporosis treatments, those taking risedronate sodium were approximately half as likely to sustain a hip fracture as those taking alendronate in the first year of treatment. 


These results were published recently in the peer-reviewed journal Osteoporosis International.
[DatePublished] => 2006-12-07 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
RISEDRONATE
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 373782
                    [Title] => Study compares two osteoporosis drugs
                    [Summary] => 

A retrospective study of over 33,000 postmenopausal women showed that among patients prescribed one of the two most popular osteoporosis treatments, those taking risedronate sodium were approximately half as likely to sustain a hip fracture as those taking alendronate in the first year of treatment. 


These results were published recently in the peer-reviewed journal Osteoporosis International.
[DatePublished] => 2006-12-07 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with